Noven Therapeutics Report issue

Founded: Miami FL United States (1987)
Status: Acquired by Hisamitsu Pharmaceutical Co., Inc. (2009)

Organization Overview

First Clinical Trial
2004
NCT00466791
First Marketed Drug
1987
lithium (lithonate)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

NOVEN | Noven Pharmaceuticals, Inc. | NOVEN PHARMS INC | NOVEN THERAP | Noven Therapeutics